PUBLIC COMPANY
saveInSilico Medicine
updated 2mo ago
community read0 votes
pipeline
4
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
1Preclinical2Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlightAfter two rejections, Replimune has made it across the regulatory finish line with its advanced melanoma therapy. Meanwhile, the last of the major pharmas, including Eli Lilly and Novo Nordisk, rep…biospace · 2d ago
- After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’Insilico Medicine CEO Alex Zhavoronkov’s mad dash across the BIO International Convention in June attracted plenty of eyes. But the executive would prefer industry watchers gawk at the billions of…biospace · 3d ago
- Why Big Pharma is chasing the industry’s most-powerful supercomputerBristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI agents can speed drug discovery.biopharma_dive · 7d ago
- From confidence to capital: Positioning biotech for the next growth cycleHow can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.biopharma_dive · 18d ago
- How well are AI-discovered drugs faring in the clinic?Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.biopharma_dive · 28d ago
- Insilico, Bora Pharma reveal plans for AI-driven manufacturing companyInsilico Medicine and Taiwan-based CDMO Bora Pharmaceuticals are launching a new company with an AI-driven biologics manufacturing platform in a bid to compete with service providers headquartered…endpoints · 1mo ago
- STAT+: AI medical devices’ dirty FDA secretIn this edition of STAT's AI Prognosis newsletter: A look at the quirks of the most common FDA medical device approval pathway, sepsis algorithms, and more.stat · 3mo ago
- STAT+: When the path to good AI is littered with bad dataIn this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI models to be useful in health care.stat · 3mo ago
- STAT+: Why conversations around health AI may be evolving beyond hypeIn this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.stat · 3mo ago
comments(0)
5-min edit window · permanent after that